Cutaneous Toxicities of T-Cell–Redirecting Therapies in Multiple Myeloma: An EADV Task Force Position Paper and Practical Recommendations

Clinical Lymphoma, Myeloma & Leukemia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles